Company

Early detection of cancer.

Leadership

At EarlySure, our people are our most valuable asset. We are a team with expertise in NGS laboratory experiments
and clinical NGS data analysis.
We have different cultural and educational backgrounds, but our goal is the same:
Changing the way cancer is diagnosed, treated, and viewed.


Simrithi Bathija

C.E.O

Simrithi Bathija is a visionary leader who seamlessly blends glamour with purpose. As the CEO of Early Sure and former Miss India International, she champions a mission rooted in health, wellness, and social upliftment.

Beyond the crown, Simrithi uses her platform to raise awareness about cancer prevention, holistic well-being, and healthy living. Guided by her philosophy — “A fit mind and a fit body can change the way we live” — she works passionately to advance the vision of a Healthy India.

Through her initiatives and influence, Simrithi is redefining what it means to be a modern role model — one where beauty, health, and responsibility go hand in hand. Her belief that “change begins with conversation” drives her ongoing efforts to inspire and empower others toward healthier, more conscious lifestyles.

Jay Motghare

Director

Mr. Jay Prakash Motghare, Founder and Whole-time Director, brings over 15 years of leadership and operational experience across diverse industries. A graduate of Nagpur University with a Bachelor’s degree in Arts, he has previously worked with reputed organizations such as Progeon Limited, ADFC Private Limited, GE Money, and Citi Corporation Limited.


Driven by a vision to contribute to India’s healthcare advancement, Mr. Motghare established the company with a focus on delivering reliable and technology-driven cancer diagnostic solutions. His strategic direction and commitment to innovation have been central to the company’s growth and research initiatives.


As Whole-time Director, he oversees business operations with a strong emphasis on research and development, strategic planning, business expansion, and customer engagement—ensuring that the company continues to advance in the field of early and accurate cancer detection.